The Adiponectin-AdipoR1 Axis Mediates Tumor Progression and Tyrosine Kinase Inhibitor Resistance in Metastatic Renal Cell Carcinoma

DOI: 10.1016/j.neo.2019.07.004

Keywords: RCC, renal cell carcinoma, mRCC, metastatic renal cell carcinoma, TKIs, tyrosine kinase inhibitors, APN, Adiponectin, PD, progressive disease, PFS, progressive-free survival, OS, overall survival, HR, hazard ratio, CI, confidence interval, EMT, epithelial–mesenchymal transition

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text